TY - JOUR
T1 - A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status
AU - Louwman, Woutera
AU - Aarts, MJ
AU - Houterman, S (Saskia)
AU - van Lenthe, Frank
AU - Coebergh, Jan Willem
AU - Heijnen, Maryska
PY - 2010
Y1 - 2010
N2 - BACKGROUND: Comorbidity and socioeconomic status (SES) may be related among cancer patients. METHOD: Population-based cancer registry study among 72 153 patients diagnosed during 1997-2006. RESULTS: Low SES patients had 50% higher risk of serious comorbidity than those with high SES. Prevalence was increased for each cancer site. Low SES cancer patients had significantly higher risk of also having cardiovascular disease, chronic obstructive pulmonary diseases, diabetes mellitus, cerebrovascular disease, tuberculosis, dementia, and gastrointestinal disease. One-year survival was significantly worse in lowest vs highest SES, partly explained by comorbidity. CONCLUSION: This illustrates the enormous heterogeneity of cancer patients and stresses the need for optimal treatment of cancer patients with a variety of concomitant chronic conditions. British Journal of Cancer (2010) 103, 1742-1748. doi:10.1038/sj.bjc.6605949 www.bjcancer.com Published online 26 October 2010 (C) 2010 Cancer Research UK
AB - BACKGROUND: Comorbidity and socioeconomic status (SES) may be related among cancer patients. METHOD: Population-based cancer registry study among 72 153 patients diagnosed during 1997-2006. RESULTS: Low SES patients had 50% higher risk of serious comorbidity than those with high SES. Prevalence was increased for each cancer site. Low SES cancer patients had significantly higher risk of also having cardiovascular disease, chronic obstructive pulmonary diseases, diabetes mellitus, cerebrovascular disease, tuberculosis, dementia, and gastrointestinal disease. One-year survival was significantly worse in lowest vs highest SES, partly explained by comorbidity. CONCLUSION: This illustrates the enormous heterogeneity of cancer patients and stresses the need for optimal treatment of cancer patients with a variety of concomitant chronic conditions. British Journal of Cancer (2010) 103, 1742-1748. doi:10.1038/sj.bjc.6605949 www.bjcancer.com Published online 26 October 2010 (C) 2010 Cancer Research UK
U2 - 10.1038/sj.bjc.6605949
DO - 10.1038/sj.bjc.6605949
M3 - Article
C2 - 20978508
SN - 0007-0920
VL - 103
SP - 1742
EP - 1748
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 11
ER -